Oxidoreductases TRIZ Cases

Mucor-derived flavin-binding glucose dehydrogenases eliminate measurement interference from maltose, galactose, and xylose in blood samples.

An implantable RET sensor detects protein levels in vivo through fluorescence resonance energy transfer, avoiding invasive sampling.

Directed evolution of RebH mutants enhances regioselectivity and thermal stability, enabling arene halogenation without harsh chemical oxidants.

S3H enzyme converts salicylic acid into 2,3-DHBA to balance disease resistance against premature leaf senescence.

Specific mutations in the P450 enzyme boost catalytic efficiency, resolving low enzymatic activity that hinders industrial steroid hormone synthesis.

Genetically modified host cells express nucleic acids encoding isoprenoid modifying enzymes to enable efficient biosynthesis of complex compounds.

Flavin monooxygenase overexpression synthesizes trimethylamine N-oxide to resolve protein overstabilization and fitness costs during drought stress.

MTHFR66 protein metabolizes dicamba into non-toxic compounds, enabling effective weed control while preventing crop damage.

Codon optimization of epimerase and isomerase genes increases enzyme concentration, lowering production costs for psicose and allose.

Thermogemmatispora 3-epimerase resolves enzyme instability at high temperatures, enabling efficient industrial D-allulose production.

A universal left half-TALEN pairs with variable right monomers to cleave multiple target genes simultaneously.

Reducing Lysine-specific Demethylase 1 in animal tissues creates accurate obesity models, enabling identification of compounds that regulate energy balance.

Genetically modified Saccharomyces cerevisiae bypasses ethanol synthesis to produce tyrosol, eliminating endotoxin risks from bacterial hosts.

Commelina communis F3'5'H gene overcomes inefficient cross-breeding by producing five times more delphinidin for reliable blue flower color.

Introducing a novel nitrogen fixation enzyme into Escherichia coli eliminates the need for metallic cofactors like vanadium or molybdenum in growth media.

Engineered P450 BM3 enzymes replace toxic metal catalysts, enabling selective cyclopropanation under mild conditions.

Targeted amino acid substitutions at positions 287 and 392 enhance firefly luciferase thermostability, resolving rapid luminescence decay during heat exposure.

Engineered ketoreductase polypeptides catalyze asymmetric reduction of 4-hydroxy-2-butanone to (R)-(−)-1,3-butanediol with high stereoselectivity.

Heterologous ectABC expression in E. coli overcomes halophilic yield limits, achieving 50 g/L ectoine without high salt requirements.

Heterologous expression of archaeon superoxide reductase in plant cells manages reactive oxygen species to increase disease resistance and stress tolerance.

Modifying selectable marker sequences to reduce translation efficiency and increase selection pressure in recombinant host cells.

Protease digestion of hemoglobin eliminates variance-related errors in point-of-care testing, enabling accurate HbA1c quantification.

Amino acid substitutions in engineered glucose isomerase variants enable high enzymatic activity at acidic pH levels while resisting calcium ion inhibition.

Replacing pyruvate dehydrogenase with pyruvate synthase eliminates CO2 decarboxylation losses, thereby increasing L-amino acid productivity.

Merging elongase and desaturase domains into one multizyme reduces pathway complexity while enhancing the yield of docosahexaenoic acid in host organisms.

Inactivating the DMR6 protein resolves the contradiction between broad pathogen recognition and resistance durability, preventing stunted growth.

Combining oxidizing agents, metallic ingredients, and transglutaminase enables high-quality cheese production from ultra-high temperature sterilized milk.

Engineered lyase variant catalyzes asymmetric synthesis of S-phenylacetylcarbinol with 97% enantiomeric excess, eliminating complex chiral separation processes.

Targeted amino acid substitutions in the flavodehydrogenase domain reduce glucose and galactose interference while maintaining lactose oxidation activity.

Enzymatic hydroxylation replaces costly ruthenium catalysts, eliminating complex recycling steps while maintaining high optical purity.

Isolated protease polypeptides from Psychrobacillus psychrodurans maintain enzymatic activity during cold wash cycles.

A coupled biocatalytic process converts chenodeoxycholic acid to ursodeoxycholic acid using matched enzyme cofactors.

Engineered yeast strains produce methionine using reduced sulfur sources like methanethiol, eliminating hazardous chemical synthesis waste.

Engineering coryneform bacteria with the Entner-Doudoroff pathway resolves low biorefinery productivity by boosting saccharide conversion rates.

Ketoreductase regenerates NADH cofactors for amino acid dehydrogenase, sustaining reaction efficiency while maintaining high enantiomeric excess.

Segmenting epimerases into oxidase and reductase components boosts alkaloid conversion yields.

A JMJD3 inhibitor increases H3K27me3 levels on NOTCH1 target genes to suppress leukemia cell proliferation.

Engineered recombinant host cells boost fatty acid derivative productivity by modifying biosynthetic pathways, resolving yield and complexity trade-offs.

Mutant glutamate dehydrogenase catalyzes reductive amination of PPO substrate to produce L-glufosinate.

Double-stranded RNA molecules silence HAO1 gene expression to lower oxalate production and delay kidney disease progression in primary hyperoxaluria type 1.

Site-directed mutagenesis creates enzyme catalysts that resolve the trade-off between high optical purity and production cost in pharmaceutical synthesis.

Endogenous promoters drive PUFA biosynthesis in thraustochytrids, resolving the trade-off between productivity and genetic complexity.

Replacing formate dehydrogenase with glucose dehydrogenase eliminates CO2 emissions and pH shifts while enabling high-concentration fructose conversion.

A mutant hydroxyphenylpyruvate dioxygenase polypeptide confers herbicide tolerance through specific amino acid substitutions at position 372.

Genetically modified filamentous fungus produces low viscosity enzyme compositions.

Mutated enzymes and transformed E. coli strains boost catalytic activity to replace costly chemical synthesis with efficient biological production.

Engineered yeast cells synthesize chondroitin using specific metabolic enzymes, replacing laborious animal extraction with a safer, scalable biological process.

Recombinant bacterial host cells convert ectoine into hydroxyectoine using ectD hydroxylase, overcoming low titers and high costs of traditional biosynthesis.

Genetically modified diatoms overexpress the OvoA enzyme to produce ovothiols through controlled metabolic pathways.